Denis D. Tyrer

Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.

I Kline, John M. Venditti, Denis D. Tyrer et al. · PubMed · 1966 · 39 citations

Hematological Malignancy, Leukemia L1210, Oncology +13

The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.

I Kline, John M. Venditti, J. A. R. Mead et al. · PubMed · 1966 · 33 citations

Advanced Leukemia L1210, Antileukemic Effectiveness, Immunology +17

Duration of Drug Levels in Mice as Indicated by Residual Antileukemic Efficacy

I Kline, M Gang, Denis D. Tyrer et al. · Chemotherapy · 1968 · 31 citations

Therapeutic Drug Monitoring, Oncology, Preclinical Drug Evaluation +10

Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.

I Kline, John M. Venditti, Denis D. Tyrer et al. · PubMed · 1966 · 21 citations

Hematological Malignancy, Leukemia L1210, Oncology +9

Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Denis D. Tyrer, I Kline, John M. Venditti et al. · PubMed · 1967 · 21 citations

Pathology, Pharmacotherapy, Tumor Biology +20